Courage Never Goes Out of Style

Today I celebrate, Liz Parrish, CEO of BioViva USA, Inc. I met Liz last year here in FL while at a wellness summit. She discussed her latest gene therapies and how they would reverse aging and the diseases associated with aging. She was confident and convicted…a woman on a mission. She is one that was deteremined to not let any obstacle stand in her way of implementing these therapies, but here in the U.S. it was not “legal” to perform these activities, so she travelled to Colombia where she became patient 0 and implemented the telomere therapy on herself. To date, the therapy was successful and lengthening her telomeres and adding 20 years back to her telomeres in terms of aging.

Leaders go first and Liz is blazing the trail by leading by example. Her courage and these therapies are revolutionizing the world of aging. This is cutting edge science targeting & correcting the root cause of aging…telomere shortening. We die when our telomeres get to short and can’t repilcate anymore. Now this does not excuse each person from living a healthy lifestyle because we all know that oxidative stress, diseases, etc. contribute to the accleleration of the shortening of telomeres so we all have to do our part and even if we add to via these cutting edge therapies, our behaviors and lifestyle still have a subtraction column.

I am so grateful and so proud of Liz and I truly feel she and this accomplishment should be celebrated. She is a pioneer, a leader, a brave and compassionate soul on a mission to reverse aging and to free people from physical suffering and I know that she will fight the good fight until these therapies are a reality for all people. Although Liz was patient zero she had a team and investment partners, Deep Knowledge Life Sciences, for making this dream come true so a shout out to all those who believed in her and her vision. I can’t wait to see what the future holds and be able to become a patient soon. For more information about the article go to www.bioviva-science.com and the article is under News.